Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease - Wikidata - wikimedia - TriplyDB

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease

http://www.wikidata.org/entity/Q34557931

about

Interventions for preventing silent cerebral infarcts in people with sickle cell disease Interventions for preventing silent cerebral infarcts in people with sickle cell disease Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia Stroke in patients with sickle cell disease.Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.How I manage cerebral vasculopathy in children with sickle cell disease.Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.Understanding sickle cell brain drain.Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.Peripheral vasoconstriction and abnormal parasympathetic response to sighs and transient hypoxia in sickle cell disease.Effects of chronic transfusions on abdominal sonographic abnormalities in children with sickle cell anemia How I treat and manage strokes in sickle cell disease.Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia.Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions.Prospects for primary stroke prevention in children with sickle cell anaemia Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease.HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy.Acute silent cerebral ischemic events in children with sickle cell anemia.Applicability of the SMART Model of Transition Readiness for Sickle-Cell Disease Current management of sickle cell anemia.Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature.Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE.Cerebral infarction in children with sickle cell disease: a concise overview.The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.Indications and complications of transfusions in sickle cell disease.Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia.The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.Blood and marrow transplantation for sickle cell disease: is less more?Current concepts in pediatric stroke.Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.

P2860

Q24186853-E680E8B6-08D7-46F4-9F53-052C0B24F98A Q24200712-27DBC58B-9FE5-4C34-9A69-712D90A66861 Q24202463-A2981E0C-B0EF-4C43-9099-BEE2E44D9B8B Q27026479-41310059-1519-415A-AF90-7269F409AD10 Q30650303-70C4CB15-9E03-46F8-BA3D-BDAEB79DF4A1 Q30830149-EC5CCBDC-B682-4428-BC1D-0E692CB520D3 Q30945117-97B0C7B6-F6BE-427C-9670-27F45B520002 Q33679897-C81E5B5B-E375-413C-B258-0E56C0121060 Q33804615-283F9C4C-0FAC-498D-9512-F4A862186AAB Q33919537-D3B57FC1-0A67-4CA6-A54A-F65213476CA4 Q34019554-D197167F-3AC7-43FB-B4C7-342CAD06DEBB Q35007607-06ED5249-F610-4670-AE85-DC40236DF866 Q35153756-CF024051-6341-4257-8C8C-70D503ACCF08 Q35219737-B4FA7B74-5F51-45EC-B6F9-8E17DC8B92D1 Q35613413-F53D271E-960E-4B59-AD36-E0A3C568BA42 Q35743944-115D8F69-5319-4881-AF58-3529348418B7 Q35754765-A1CA62E8-F7D6-4BC0-BA6D-DF6368DD580C Q35953361-61602430-C587-4D0E-974C-76881BBD64CE Q35999807-1C8E628C-A3D4-49EE-8829-4F02CB8B6694 Q36038875-35F85124-C95D-4F3B-BC62-4597B68C50BE Q36105129-46B8C619-61D3-4007-B6A4-D9C9873193C4 Q36349336-525EEF9D-5828-4E41-B41E-0F511245A4F3 Q36425417-A2425228-D157-41B0-850F-0A6923004615 Q36434471-011E355B-C831-4F7A-8E42-77E001063A23 Q36914931-0E5DA566-73FB-403E-A665-E4CCCEF9DB2F Q36954289-E674FE79-A948-4278-A99A-3180DDCA01B8 Q37040238-70F304C5-05D4-4F12-A4F0-E36CEADF83DE Q37061928-40E1E3FC-4F3E-4875-A85D-01EC4AD7EB0A Q37154176-6A2AEA16-0D06-4762-91E3-8FB93D20006A Q37178468-CB062C2B-20A3-4F9A-BD95-223FF5AC6F84 Q37238159-2F8EE097-16A0-4EEB-8F08-5826AA8C1EC9 Q37563797-8167932F-34E6-4028-AE2B-0B4B31DB8C73 Q37941865-E7EB948B-0A9F-4BE4-A805-0EB96DE3C982 Q37955226-ED33F645-F5D9-4F18-9B06-99EC3AA42E11 Q38008292-89679541-4AD1-42CD-9916-0AA9A00E81E9 Q38089946-E7785D63-F50E-44A4-9110-26B990A8DE8D Q38176054-F6F7C18A-4D6A-4966-9C95-E5A68F6120B6 Q38248808-713FA3F9-914C-42F9-917F-0B217718831D Q38270408-C2AAB760-1B97-4F21-AD3F-C95C4B66B8BD Q38627797-C7366A8D-5D0A-4885-9D33-64DFA587F27D

P2860

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease

http://www.wikidata.org/entity/Q34557931

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@ast

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@en

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@nl

type

label

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@ast

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@en

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@nl

prefLabel

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@ast

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@en

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@nl

P1433

Q34557931-8C9D9362-E73E-439B-A2D7-AF8EF0DC596F

P1476

Q34557931-A9082926-75B7-4741-B024-FA5194B4E32C

P2093

Q34557931-0C7D4CC8-E56A-4DFE-90C1-6D34BF66F8DB

Q34557931-19DA5692-086C-41D7-BBAC-002AA815D91E

Q34557931-2C5D3E36-3950-4AFE-87FE-1E259B3186CF

Q34557931-2F49F3E0-1E4D-474F-83C3-192A86A5A26B

Q34557931-3E19BF88-C841-4D15-B714-71AA58B39054

Q34557931-614D50F0-BDC3-4A0C-B483-C2C68FD8ABC9

Q34557931-733FBAFA-4908-4AE9-BEC2-B7FBA86ADE97

Q34557931-7B73555C-91DA-4734-9124-BD947B0DDCA6

Q34557931-838E139F-ADC0-4B67-92DA-04B99CF3B89F

Q34557931-88326BEA-8C6C-423D-8C41-D8DEFC39A425

P2860

Q34557931-243C726F-CDBF-471C-9AFE-3AA5BA9A2D1E

Q34557931-470ABFB5-32BA-4367-BA13-52056D52519D

Q34557931-589A6759-3D1A-492C-8E91-5EE881420BA9

Q34557931-6FE18975-C20C-4CA4-BCDC-1030A701D565

Q34557931-7FB3B81F-F8F8-4C6F-8221-B8CA4BFFF1F4

Q34557931-89AF9B32-50A2-4C7C-BEA9-B58278DF19FA

Q34557931-9CD1C1C4-4883-4462-A03E-E97351534BF6

Q34557931-ABEF41DE-93DA-49BF-9FB5-A7E739EC5BED

Q34557931-CAE8A899-E901-49DA-84B3-7ED7E0ED2701

Q34557931-E92C4E24-085E-44B5-87D5-04C0B7A00F4D

P304

Q34557931-B0B017A3-D8FD-4029-AACA-FC7AE0492BF0

P31

Q34557931-E6792032-47D8-4BB2-919D-4382FCDCC1B0

P356

Q34557931-196A2FA6-C507-433B-8BBF-93C31FEC7A9E

P407

Q34557931-E29A2F8E-4C30-4C17-99B5-E535409054C0

P433

Q34557931-7C016874-9246-4C08-8290-09377B34E1EF

P478

Q34557931-6CCE6EA4-6924-4038-A2CE-2176F8D30228

P50

Q34557931-74C03EBB-8DFF-4FE7-969F-2394AB26FE69

Q34557931-7FFD3C36-433B-4EED-B64D-3923EEC7B053

Q34557931-B3423DC2-B8FA-4698-A26E-C549B7A92556

P577

Q34557931-C4016A32-7C8C-4BB9-B782-6C0ACD1E2CBE

P5875

Q34557931-360818FD-812A-4527-AE98-BCC8B74496E0

P698

Q34557931-1DCBC586-1EDF-4920-8FF0-F8AB3D1BD104

P921

Q34557931-009CB3E2-960E-4C76-BF46-F22A7074314F

P932

Q34557931-43B41008-5B05-496E-9650-E637EF71FD69

P356

BLOOD-2010-01-261123

P1433

P1476

Silent cerebral infarcts occur ...... ldren with sickle cell disease

@en

P2093

Alexis A Thompson

http://www.w3.org/2001/XMLSchema#string

Gerald M Woods

http://www.w3.org/2001/XMLSchema#string

James F Casella

http://www.w3.org/2001/XMLSchema#string

Jo Howard

http://www.w3.org/2001/XMLSchema#string

JoAnne L Lacey

http://www.w3.org/2001/XMLSchema#string

Jonathan E Mullin

http://www.w3.org/2001/XMLSchema#string

Julie A Panepinto

http://www.w3.org/2001/XMLSchema#string

Kofi A Anie

http://www.w3.org/2001/XMLSchema#string

Mark Rodeghier

http://www.w3.org/2001/XMLSchema#string

Michael Noetzel

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a de novo cerebral arteriovenous malformation in a child with sickle cell disease and moyamoya arteriopathy. Case report.

Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.

Moyamoya disease and moyamoya syndrome.

Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy.

Incidence of overt and covert neurological damage in children with sickle cell disease

Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia.

Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.

Design of the silent cerebral infarct transfusion (SIT) trial.

Brain infarction in sickle cell anemia: magnetic resonance imaging correlates.

Clinical and radiological recurrence after childhood arterial ischemic stroke.

P304

772-779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-01-261123

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Fenella J. Kirkham

Christopher J Moran

P577

2010-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47403759

http://www.w3.org/2001/XMLSchema#string

P698

20940417

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3035071

http://www.w3.org/2001/XMLSchema#string